New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint-Reference-Cited by-同舟云学术

New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint

Published:2015-10 Issue: Volume:196 Page:133-138
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Rubboli Andrea,Agewall Stefan,Huber Kurt,Lip Gregory Y.H.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference48 articles.

1. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)

2. Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy;Agewall;Eur. Heart J.,2013

3. New oral anticoagulant agents — general features and outcomes in subsets of patients;Schulman;Thromb. Haemost.,2014

4. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N. Engl. J. Med.,2009

5. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N. Engl. J. Med.,2011

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Closure Device-Related Thrombosis After Anticoagulation With Dabigatran in Patients Undergoing Percutaneous Left Atrial Appendage Closure: Case Reports and Literature Review;Frontiers in Pharmacology;2020-09-08

2. Simultaneous determination of Rivaroxaban and TAK-438 in rat plasma by LC–MS/MS: application to pharmacokinetic interaction study;Bioanalysis;2020-01

3. The safety of upper gastrointestinal endoscopic biopsy in patients receiving antithrombic drugs. A single-centre prospective observational study;Gastroenterology Review;2020

4. Use and Outcomes of Triple Antithrombotic Therapy with Non-Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention;The American Journal of the Medical Sciences;2019-08

5. Antithrombotic therapy after percutaneous revascularization in patients on chronic oral anticoagulation treatment;REC: interventional cardiology (English Edition);2019-05-09